CytomX Therapeutics Inc (CTMX)
2.00
+0.04
(+2.04%)
USD |
NASDAQ |
May 16, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
December 30, 2022 | 3.713 |
December 29, 2022 | 3.644 |
December 28, 2022 | 3.574 |
December 27, 2022 | 3.365 |
December 23, 2022 | 3.597 |
December 22, 2022 | 3.551 |
December 21, 2022 | 3.504 |
December 20, 2022 | 3.481 |
December 19, 2022 | 3.551 |
December 16, 2022 | 3.644 |
December 15, 2022 | 3.690 |
December 14, 2022 | 3.806 |
December 13, 2022 | 3.783 |
December 12, 2022 | 3.574 |
December 09, 2022 | 3.597 |
December 08, 2022 | 3.760 |
December 07, 2022 | 3.667 |
December 06, 2022 | 3.806 |
December 05, 2022 | 3.969 |
December 02, 2022 | 3.969 |
December 01, 2022 | 3.969 |
November 30, 2022 | 4.038 |
November 29, 2022 | 3.946 |
November 28, 2022 | 3.992 |
November 25, 2022 | 4.201 |
Date | Value |
---|---|
November 23, 2022 | 4.154 |
November 22, 2022 | 4.433 |
November 21, 2022 | 3.969 |
November 18, 2022 | 4.038 |
November 17, 2022 | 3.713 |
November 16, 2022 | 2.808 |
November 15, 2022 | 2.762 |
November 14, 2022 | 2.948 |
November 11, 2022 | 2.994 |
November 10, 2022 | 2.924 |
November 09, 2022 | 2.878 |
November 08, 2022 | 2.855 |
November 07, 2022 | 2.901 |
November 04, 2022 | 2.901 |
November 03, 2022 | 2.901 |
November 02, 2022 | 2.948 |
November 01, 2022 | 3.040 |
October 31, 2022 | 3.040 |
October 28, 2022 | 3.127 |
October 27, 2022 | 3.011 |
October 26, 2022 | 3.15 |
October 25, 2022 | 3.057 |
October 24, 2022 | 3.057 |
October 21, 2022 | 3.080 |
October 20, 2022 | 3.011 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.467
Minimum
May 09 2022
9.637
Maximum
May 12 2020
4.167
Average
3.819
Median
Jun 24 2019
Price to Book Value Benchmarks
Amgen Inc | 33.63 |
Ocular Therapeutix Inc | 2.386 |
Bristol-Myers Squibb Co | 5.424 |
ACADIA Pharmaceuticals Inc | 5.285 |
Calidi Biotherapeutics Inc | -- |
Price to Book Value Related Metrics
PE Ratio | 10.00 |
PS Ratio | 1.308 |
Price | 2.00 |
Earnings Yield | 10.00% |
Market Cap | 155.84M |
Operating PE Ratio | 14.40 |
Normalized PE Ratio | 10.00 |